Fact check: Trump got a lot wrong about his own European travel ban
Trump’s administration was forced to correct details about the ban he announced.
Donald Trump misstated his administration’s intended actions on the coronavirus pandemic when he spoke to the nation in his prime-time address Wednesday. He also appeared to hold out false hope of an imminent treatment for the spreading disease.
TRUMP: “We will be suspending all travel from Europe, except the United Kingdom, for the next 30 days.”
THE FACTS: That’s not exactly his plan.
First, the restriction does not apply to legal permanent residents of the U.S. or their families when they are returning from Europe. It also does not apply to U.S. citizens coming back from Europe, as Trump acknowledged.
It also apparently does not apply to Ireland, Romania, Croatia, Ukraine and several other European states.
The proclamation released by the White House says the travel ban will affect the 26 European states in what’s known as the Schengen Area. That’s most of Europe, but not “all.”
___
TRUMP: “These prohibitions will not only apply to the tremendous amount of trade and cargo, but various other things as we get approval.”
THE FACT: That is also wrong.
The White House quickly clarified that the restriction on movement from Europe “only applies to human beings, not goods and cargo.”
___
TRUMP: “We are cutting massive amounts of red tape to make antiviral therapies available in record time. These treatments will significantly reduce the impact and reach of the virus.”
THE FACTS: People suffering from COVID-19 or those who get it in the current outbreak should not expect those therapies to be available to them.
Dr. Anthony Fauci of the National Institutes of Health told a congressional committee Wednesday that while antivirals are being tested, “we don’t know if it works. I don’t want to promise anything.”
An antiviral is a medicine that specifically attacks a virus to hasten recovery. An experimental drug named remdesivir, which was being developed to fight Ebola, is being tested in COVID-19 patients in the U.S. and abroad. There also are studies underway using combinations of some HIV-attacking drugs.
Recommended
Cost, access still barriers to medical care for Black Ohio women
A recent study recommended increases in Medicaid eligibility and other legislative measures to help improve health care outcomes and access for Black women in Ohio, while still spotlighting fears of discrimination among women seeking care.
By Susan Tebben, Ohio Capital Journal - October 15, 2024
Texas’ abortion laws are straining the OB/GYN workforce, new study shows
More doctors are considering leaving or retiring early, while fewer medical students are applying to obstetrics and gynecology residencies in Texas.
By Eleanor Klibanoff, Texas Tribune - October 08, 2024
Rogers says Medicare negotiating drug price reductions is ‘sugar high politics’
Former U.S. Rep. Mike Rogers (R-White Lake)said he was “passionately against” allowing Medicare to negotiate drug prices, which he referred to as “sugar high politics.”
By Jon King, Michigan Advance - October 02, 2024
